12-109768407-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032829.3(FAM222A):c.478C>A(p.Pro160Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000076 in 1,446,456 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_032829.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAM222A | NM_032829.3 | c.478C>A | p.Pro160Thr | missense_variant | 3/3 | ENST00000538780.2 | NP_116218.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAM222A | ENST00000538780.2 | c.478C>A | p.Pro160Thr | missense_variant | 3/3 | 1 | NM_032829.3 | ENSP00000443292.1 | ||
FAM222A | ENST00000358906.3 | c.478C>A | p.Pro160Thr | missense_variant | 3/3 | 5 | ENSP00000351783.3 | |||
FAM222A-AS1 | ENST00000541460.2 | n.189+4890G>T | intron_variant | 4 | ||||||
FAM222A-AS1 | ENST00000541723.5 | n.212+4890G>T | intron_variant | 2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000270 AC: 6AN: 222096Hom.: 1 AF XY: 0.0000404 AC XY: 5AN XY: 123676
GnomAD4 exome AF: 0.00000760 AC: 11AN: 1446456Hom.: 1 Cov.: 31 AF XY: 0.0000125 AC XY: 9AN XY: 719828
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 30, 2024 | The c.478C>A (p.P160T) alteration is located in exon 3 (coding exon 2) of the FAM222A gene. This alteration results from a C to A substitution at nucleotide position 478, causing the proline (P) at amino acid position 160 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at